Payment by credit card (VISA, MASTERCARD or AMX) please use our Readies payment option. Once at the check out for Readies, use the option Check Out As Guest you do not need a readies account and can pay by Credit Card.

Search

Insuman Basal (Insuman Basal) 40IU/ML

Each vial of Insuman Basal contains 40iu/ml of Insulin and comes in the 10 ml size vial and is used in treatment of Diabetes.

ATC Classification: A10AB01
Active Ingrediant: Human Insulin
Generic Name: Insuman Basal
Manufacturer: Sanofi Aventis GmbH Germany
Strength: 40IU/ML
Dosage Type: VIAL
Packaging Type: Box
Contains: 10 ML VIAL

In Stock

$5.55

Compare
SKU:58a3c6e14ae4-1

Insuman Basal Information

Pronunciation

(IN soo lin N P H)

What is this drug used for?

• It is used to lower blood sugar in patients with high blood sugar (diabetes).

Frequently reported side effects of this drug

• Injection site irritation

• Weight gain

Other side effects of this drug: Talk with your doctor right away if you have any of these signs of:

• Low blood sugar like dizziness, headache, fatigue, feeling weak, shaking, fast heartbeat, confusion, increased hunger, or sweating.

• Low potassium like muscle pain or weakness, muscle cramps, or an abnormal heartbeat.

• Vision changes

• Burning or numbness feeling

• Severe dizziness

• Passing out

• Mood changes

• Seizures

• Slurred speech

• Swelling of arms or legs

• Injection site thick skin, pits, or lumps

• Signs of a significant reaction like wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat.

Medication Safety Issues

Sound-alike/look-alike issues:

HumuLIN N may be confused with HumuLIN R, HumaLOG, Humira

NovoLIN N may be confused with NovoLIN R, NovoLOG

High alert medication:

The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs which have a heightened risk of causing significant patient harm when used in error. Due to the number of insulin preparations, it is essential to identify/clarify the type of insulin to be used.

Other safety concerns:

Cross-contamination may occur if insulin pens are shared among multiple patients. Steps should be taken to prohibit sharing of insulin pens.

Storage/Stability

Humulin N vials: Store unopened vials in refrigerator between 2°C and 8°C (36°F to 46°F; do not freeze; keep away from heat and sunlight. Once punctured (in use), vials may be stored for up to 31 days in the refrigerator between 2°C and 8°C (36°F to 46°F) or at room temperature ≤30°C (≤86°F)

Humulin N KwikPen: Store unopened in the refrigerator between 2°C and 8°C (36°F to 46°F); do not freeze; keep away from heat and sunlight. Once punctured (in use), should be stored below 30°C (86°F) for up to 14 days.

Novolin N vials: Store unopened vials in refrigerator between 2°C and 8°C (36°F to 46°F) until product expiration date or at room temperature ≤25°C (≤77°F) for up to 42 days; do not freeze; keep away from heat and sunlight. Once punctured (in use), store vials at room temperature ≤25°C (≤77°F) for up to 42 days; refrigeration of in-use vials is not recommended.

Novolin N FlexPen: Store unopened pen in the refrigerator between 2°C and 8°C (36°F to 46°F) until product expiration date or at room temperature <30°C (<86°F) for 28 days; do not freeze; keep away from heat and sunlight. Once punctured (in use), store <30°C (<86°F) for up to 28 days; refrigeration of in-use pens is not recommended.

Canadian products: Unopened vials, cartridges, and pens should be stored under refrigeration between 2°C and 8°C (36°F to 46°F) until the expiration date; do not freeze; keep away from heat and sunlight. Once punctured (in use), Humulin vials, cartridges and pens should be stored at room temperature <25°C (<77°F) for up to 4 weeks. Once punctured (in use), Novolin ge vials, cartridges, and pens may be stored for up to 1 month at room temperature <25°C (<77°F) for vials or <30°C (<86°F) for pens/cartridges; do not refrigerate.

Adverse Reactions

Frequency not defined.

Cardiovascular: Peripheral edema

Endocrine & metabolic: Hypoglycemia, hypokalemia, weight gain

Hypersensitivity: Hypersensitivity reaction

Immunologic: Immunogenicity

Local: Atrophy at injection site, hypertrophy at injection site, injection site reaction (including redness, swelling, and itching)

Neuromuscular & skeletal: Swelling of extremities

Ophthalmic: Visual disturbance

Active Ingredient

Generic Name

Alternate Names

, , , , , , , , , , , , , , , , , , , , , , , , , , ,

Strength

Dosage Type

Packaging Type

Brand

Sanofi Aventis

Back to Top
Product has been added to your cart